“…From the RNAseq data, we analyzed the expression of the oncogenes that have previously been shown to be upregulated, and characterized as tumorigenic, in RMS. Several such genes were found to be significantly repressed by PROX1 silencing: FGFR4, MYL4 (Khan et al, 2001), IGFBP5, IGF2 (El-Badry et al, 1990; Khan et al, 1999), MYOG (Gryder et al, 2017), MYCN (Williamson et al, 2005), RASSF4 (Crose et al, 2014), VANGL2 (Hayes et al, 2018), Hey1 (Belyea et al, 2011) and NOTCH3 (De Salvo et al, 2014) ( Figure 5A ). Correlation analysis of these genes with PROX1 using RMS tumor RNA expression data in MediSapiens (n = 49 tumors, http://ist.medisapiens.com/) showed significant correlation between PROX1 and six of these genes ( Supplement Figure 3 ), of which one of the strongest correlations was found between PROX1 and FGFR4 ( Figure 5B ).…”